Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medidata Solutions (MDSO)

Medidata Solutions (MDSO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,759,693
  • Shares Outstanding, K 62,456
  • Annual Sales, $ 635,700 K
  • Annual Income, $ 51,920 K
  • 60-Month Beta 1.22
  • Price/Sales 9.06
  • Price/Cash Flow 54.56
  • Price/Book 8.72
  • Price/Earnings ttm 106.02
  • Earnings Per Share ttm 0.87
  • Most Recent Earnings 0.48 on 07/23/19
  • Next Earnings Date 10/31/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.22
  • Number of Estimates 2
  • High Estimate 0.23
  • Low Estimate 0.21
  • Prior Year 0.21
  • Growth Rate Est. (year over year) +4.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.37 +0.93%
on 09/30/19
92.27 -0.05%
on 10/24/19
+0.81 (+0.89%)
since 09/27/19
3-Month
91.04 +1.30%
on 07/29/19
92.27 -0.05%
on 10/24/19
+1.00 (+1.10%)
since 07/26/19
52-Week
60.10 +53.44%
on 12/26/18
98.60 -6.47%
on 04/29/19
+22.31 (+31.91%)
since 10/26/18

Most Recent Stories

More News
Phreesia Names Randy Rasmussen as Chief Accounting Officer

Phreesia, Inc. (NYSE: PHR) the nation's leading patient intake platform, today announced the appointment of Randy Rasmussen as Chief Accounting Officer, reporting to Tom Altier, Phreesia's Chief Financial...

PHR : 28.66 (-0.86%)
MDSO : 92.22 (-0.02%)
SAP : 135.00 (-0.55%)
Dassault Systemes Completes Acquisition of Medidata Opening Up a New World of Virtual Twin Experiences for Healthcare

Dassault Systemes (Paris:DSY) (Euronext Paris: #13065, DSY.PA) today announced the completion of its acquisition of Medidata Solutions, Inc. (NASDAQ: MDSO), whose clinical expertise and cloud-based solutions...

MDSO : 92.22 (-0.02%)
FTI Consulting Set to Join S&P MidCap 400; KKR Real Estate Finance Trust to Join S&P SmallCap 600

S&P SmallCap 600 constituent FTI Consulting Inc. (NYSE: FCN) will replace Medidata Solutions Inc. (NASD: MDSO) in the S&P MidCap 400, and KKR Real Estate Finance Trust Inc. (NYSE: KREF) will replace FTI...

FCN : 108.69 (+0.47%)
MDSO : 92.22 (-0.02%)
KREF : 19.90 (+0.25%)
SPGI : 268.10 (+0.09%)
Medidata Solutions (MDSO) Earnings Expected to Grow: What to Know Ahead of Q3 Release

Medidata (MDSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MDSO : 92.22 (-0.02%)
Medidata Solutio Shares Up 17.3% Since SmarTrend's Buy Recommendation (MDSO)

SmarTrend identified an Uptrend for Medidata Solutio (NASDAQ:MDSO) on April 15th, 2019 at $78.18. In approximately 6 months, Medidata Solutio has returned 17.33% as of today's recent price of $91.72.

MDSO : 92.22 (-0.02%)
Medidata Introduces Study Site Analytics, New Feature for Sites to Receive Real-Time Performance Metrics and Benchmarks

FDA inspections continue to highlight recurring issues with site performance throughout the past ten years. To prevent performance issues, sites rely on actionable performance information prior to preparing...

MDSO : 92.22 (-0.02%)
Forbes Names Medidata CEO to "America's Most Innovative Leaders" List

Forbes named Tarek Sherif, CEO of Medidata (NASDAQ: MDSO), to their list of "America's Most Innovative Leaders." Mr. Sherif ranked among today's top 100 most creative and successful business minds.

MDSO : 92.22 (-0.02%)
Medidata Solutio Has Returned 17.0% Since SmarTrend Recommendation (MDSO)

SmarTrend identified an Uptrend for Medidata Solutio (NASDAQ:MDSO) on April 15th, 2019 at $78.18. In approximately 5 months, Medidata Solutio has returned 17.01% as of today's recent price of $91.47.

MDSO : 92.22 (-0.02%)
Uptrend Call Working As Medidata Solutio Stock Rises 17.4% (MDSO)

SmarTrend identified an Uptrend for Medidata Solutio (NASDAQ:MDSO) on April 15th, 2019 at $78.18. In approximately 5 months, Medidata Solutio has returned 17.42% as of today's recent price of $91.79.

MDSO : 92.22 (-0.02%)
For Precision Medicine to Achieve Its Potential, Life Science Leaders Embrace New Data and AI Models

Eighty-four percent of senior life science executives agree that precision medicine represents a new era in drug development, according to the Newsweek Vantage report, Precision Medicine: Creating Value...

BMY : 56.41 (-0.12%)
MDSO : 92.22 (-0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade MDSO with:

Business Summary

Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently...

See More

Key Turning Points

2nd Resistance Point 92.28
1st Resistance Point 92.25
Last Price 92.22
1st Support Level 92.20
2nd Support Level 92.18

See More

52-Week High 98.60
Last Price 92.22
Fibonacci 61.8% 83.89
Fibonacci 50% 79.35
Fibonacci 38.2% 74.81
52-Week Low 60.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar